Dr. Daphnee Moise-johnson, MD
General Practice (General Practice Physician)
- Medicare participating
At a glance
- Medical school
- University of South Florida College of Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 52
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: University of South Florida College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
General Practice Physician primary
FL license ME93843 -
Emergency Medicine Physician
FL license ME93843 -
Infusion Therapy Clinic/Center
FL license ME93843
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sarasota Memorial Hospital Sarasota, FL
Medical groups
- Good Business LLC (5 clinicians)
- 360 Medical Care LLC (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 52
- Services billed
- 7,403
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 93 | 14 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 69 | 11 |
| Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | 34 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 3 companies reported 3 payments worth $85.61 in total to this clinician.
| Revance Therapeutics, Inc. | $47.43 |
|---|---|
| Novartis Pharmaceuticals Corporation | $19.57 |
| AstraZeneca Pharmaceuticals LP | $18.61 |
| Food and Beverage | $85.61 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $414,712 in research payments for these studies, mostly to the institutions running them.
- A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age
Seqirus USA Inc · Completed · NCT06087640 - A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19
ModernaTX, Inc. · Completed · NCT05815498 - The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older
Seqirus USA Inc · Completed · NCT06015282 - An interventional efficacy and safety phase 3 doubleblind 2ARM study to investigate orally administered ibuzatrelvir compared with placebo in nonhospitalized symptomatic adult and adolescent participants with COVID19 …
Pfizer Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.